← FDA Drug Approvals (Drugs@FDA)
ROFLUMILAST
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2018-07-13
Drug application
- FDA Application #
ANDA208257- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ROFLUMILAST
- Generic name
- Roflumilast
- Active ingredients
- ROFLUMILAST
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PHARMOBEDIENT
- First approval
- 2018-07-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown